Clinical development of monoclonal antibody-based drugs in HIV and HCV diseases
<p>Abstract</p> <p>Today there are many licensed antiviral drugs, but the emergence of drug resistant strains sometimes invalidates the effects of the current therapies used in the treatment of infectious diseases. Compared to conventional antiviral drugs, monoclonal antibodies (mA...
Main Authors: | Flego Michela, Ascione Alessandro, Cianfriglia Maurizio, Vella Stefano |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2013-01-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1741-7015/11/4 |
Similar Items
-
Monoclonal Antibody Therapies against Anthrax
by: Zhaochun Chen, et al.
Published: (2011-08-01) -
Generation of Anti-HIV-1 envelope monoclonal antibodies using B-cells
from HIV-1 sub-type C infected individuals with high levels of neutralizing antibodies
by: Nhlapo, Jabulani
Published: (2006) -
Shear thinning in monoclonal antibodies
by: Paudel, Subhash
Published: (2016) -
Protein A chromatography in monoclonal antibody purification
by: Curtis, Michael
Published: (2018) -
Biotherapeutics: Challenges and Opportunities for Predictive Toxicology of Monoclonal Antibodies
by: Dale E. Johnson
Published: (2018-11-01)